scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1360-0443.2003.00326.X |
P8608 | Fatcat ID | release_3wcmnxplobeofaqzl66m5c54ya |
P698 | PubMed publication ID | 12653817 |
P5875 | ResearchGate publication ID | 10840808 |
P50 | author | Alfred Uhl | Q72333475 |
P2093 | author name string | Lucas Wiessing | |
Ludwig Kraus | |||
Rita Augustin | |||
Martin Frischer | |||
Petra Kümmler | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Norway | Q20 |
P304 | page(s) | 471-485 | |
P577 | publication date | 2003-04-01 | |
P1433 | published in | Addiction | Q4681106 |
P1476 | title | Estimating prevalence of problem drug use at national level in countries of the European Union and Norway | |
P478 | volume | 98 |
Q37018144 | A latent class analysis of drug abuse in a national Swedish sample |
Q35607184 | A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men. |
Q30991879 | Addiction profile in probation practices in Turkey: 5-year data analysis |
Q35085285 | Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study |
Q37260790 | Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents |
Q33946544 | Clinical features of drug abuse that reflect genetic risk |
Q58271194 | Cocaine and crack use and dependence in Europe – experts view on an increasing public health problem |
Q31135493 | Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities. |
Q79315521 | Completeness and accuracy of the drug treatment reporting system in Dublin, Ireland |
Q52287466 | Cost of addiction in Europe. |
Q47677182 | Cost of disorders of the brain in Denmark |
Q36801392 | Cross-generational transmission from drug abuse in parents to attention-deficit/hyperactivity disorder in children |
Q35907793 | Environmental clustering of drug abuse in households and communities: multi-level modeling of a national Swedish sample |
Q37238707 | Environmental influences on familial resemblance for drug abuse in first-cousin pairs: a Swedish national study |
Q31145999 | Estimating heroin epidemics with data of patients in methadone maintenance treatment, collected during a single treatment day. |
Q39651239 | Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir |
Q36579571 | Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. |
Q36496285 | Estimation of cocaine consumption in the community: a critical comparison of the results from three complimentary techniques |
Q64075864 | Estimation of the Number of People With Opioid Addiction in Germany |
Q35058613 | Exposure to peer deviance during childhood and risk for drug abuse: a Swedish national co-relative control study |
Q34258984 | Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study |
Q50052349 | High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use. |
Q36885117 | Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 |
Q35604603 | Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission? |
Q47766427 | Maternal and neonatal outcomes following methadone substitution during pregnancy |
Q33592665 | Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. |
Q37549535 | Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence |
Q37728117 | Peer deviance, parental divorce, and genetic risk in the prediction of drug abuse in a nationwide Swedish sample: evidence of environment-environment and gene-environment interaction |
Q45069634 | Prediction of drug abuse recurrence: a Swedish National Study |
Q47313450 | Prevalence of problem drug use and injecting drug use in Luxembourg: a longitudinal and methodological perspective |
Q37169169 | Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence |
Q33675971 | Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources |
Q34380661 | Risk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuse |
Q47290924 | Sources of Parent-Child Transmission of Drug Abuse: Path Analyses of Not-Lived-With Parental, Stepparental, Triparental, and Adoptive Families |
Q43631540 | Substance use at admission to an acute psychiatric department |
Q34514187 | The causes of parent-offspring transmission of drug abuse: a Swedish population-based study |
Q36757752 | The rearing environment and risk for drug abuse: a Swedish national high-risk adopted and not adopted co-sibling control study |
Q28533642 | Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007 |
Q33723159 | Unexpected adverse childhood experiences and subsequent drug use disorder: a Swedish population study (1995-2011). |
Q33302205 | Validating estimates of problematic drug use in England |
Q47247667 | Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users. |
Q36720099 | Within-family environmental transmission of drug abuse: a Swedish national study |
Search more.